Fundamentals of antiarrhythmic drug classification
The systematization of drugs used to combat cardiac rhythm disorders relies on two key parameters: the mechanisms of action of the substances and their actual clinical application.
Historically, several approaches have emerged to structure this group of medications. The classification proposed by Vaughan Williams in 1970 has gained the widest distribution and recognition, and has since been repeatedly supplemented and refined in light of new pharmacological data.
General characteristics of Class I
The first major section of the modern system unites pharmacological agents that affect electrophysiological processes in the myocardium.
- Definition: Class I drugs are sodium channel blockers.
- Historical name: Previously, in medical literature and practice, these medications were referred to as “membrane-stabilizing agents”.
Subclasses and criteria for their division
Within the first class, drugs are not homogeneous. Currently, they are clearly divided into three separate subclasses: IA, IB, and IC.
The division of pharmacological agents into these subgroups is based strictly on three criteria:
- Subtle nuances of the mechanism of action, specifically the characteristics of drug binding to sodium channels.
- The nature and degree of influence on the electrophysiological parameters of the heart muscle.
- The specifics of the clinical application of each subclass.
Briefly: answers to topical questions
Which specific drugs belong to subclass IA antiarrhythmic agents?
Subclass IA antiarrhythmic agents include quinidine, procainamide, and disopyramide. These drugs are sodium and potassium channel blockers that prolong phases 0, 3, and 4 of the action potential. The use of these medications is associated with the risk of developing specific side effects:
- Quinidine — causes cinchonism (headache, tinnitus, visual disturbances).
- Procainamide — can provoke drug-induced lupus.
- Disopyramide — exhibits anticholinergic effects (dry mouth, urinary retention, constipation).
How do subclass IB drugs affect the duration of the cardiomyocyte action potential?
Subclass IB drugs do not prolong the duration of the cardiomyocyte action potential. Unlike other subclasses, their administration does not increase the QT interval on the ECG. These medications (lidocaine, mexiletine) bind to inactivated sodium channels. They show the highest efficacy at high heart rates, when channels are more frequently in the inactivated state, while they are largely ineffective during bradycardia and sinus rhythm.
What is the mechanism of action of Class II antiarrhythmic drugs?
The mechanism of action of Class II antiarrhythmic drugs consists of $\beta$-adrenoreceptor blockade. This group of drugs is used for tachyarrhythmias and extrasystoles. In particular, they serve as one of the targets of therapy in re-entrant tachycardias by acting on the atrioventricular node. However, their use may be associated with risks: in Wolff-Parkinson-White syndrome, beta-blockers can increase ventricular contraction rate in the event of atrial fibrillation conducted via an accessory atrioventricular pathway.
Which medicinal products are included in Class III antiarrhythmic drugs?
Class III antiarrhythmic drugs include agents whose primary mechanism of action is potassium channel blockade. The group is pharmacologically heterogeneous and includes:
- Amiodarone — a drug with a mixed action profile, the mechanism of which includes K⁺ channel blockade and other effects.
- Sotalol — an agent with a mixed action profile, combining the properties of a K⁺ channel blocker and a β-blocker.
- Ibutilide — a selective K⁺ channel blocker.
- Nibentan — a selective K⁺ channel blocker.
The electrophysiological effect of Class III drugs is associated with delayed repolarization and an increase in the overall action potential duration.
What is the mechanism of action of Class IV antiarrhythmic drugs?
The mechanism of action of Class IV antiarrhythmic drugs consists of calcium channel blockade. L-type voltage-gated calcium channels dominate in the heart and blood vessels; they open upon membrane depolarization, allowing calcium ions to enter the cell. The group is heterogeneous, and channel sensitivity depends on the chemical structure of the substance. Non-dihydropyridine calcium channel blockers are used as antiarrhythmic agents of this class:
- Verapamil — a non-dihydropyridine calcium antagonist.
- Diltiazem — a non-dihydropyridine calcium antagonist.
Which antiarrhythmic drugs are not included in the Vaughan Williams classification?
In the provided materials, in addition to the four main classes of antiarrhythmic drugs, additional agents are identified:
- Adenosine — effective in supraventricular tachyarrhythmias.
- Cardiac glycosides — effective in supraventricular tachyarrhythmias.
- Potassium and magnesium preparations — effective in extrasystoles against the background of hypokalemia.
Class I is "sodium" (sodium channel blockers), and the division into IA, IB, IC is memorized by three criteria: mechanism (binding), electrophysiology, and clinical profile.
Class and exam questions
What is the classification of antiarrhythmic agents based on?
The classification is based on clinical application and mechanisms of drug action.
Who is the author of the main classification and in what year did it appear?
The basic classification was proposed by Vaughan Williams in 1970 with subsequent additions.
What were Class I drugs previously called?
Previously, these medications were referred to as "membrane-stabilizing agents".
What subclasses are Class I drugs divided into and what are the criteria?
They are divided into subclasses IA, IB, and IC according to three criteria: nuances of channel binding, effect on cardiac electrophysiology, and clinical application.
What else to study on this topic
- Alternative classification systems (Lewis, Singh, ATC classification)
- Detailed analysis of subclass IA sodium channel blockers
- Characteristics of subclass IB and its channel-binding features
- Electrophysiological effects of subclass IC
- Clinical indications for prescribing Class I drugs
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Classification of Antiarrhythmic Drugs" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the "Antiarrhythmic Agents" section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.